MacroGenics Inc. Company Profile

11:42 EDT 18th March 2018 | BioPortfolio

MacroGenics, Inc. is developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals.


1500 East Gude Drive
United States of America


Phone: 301.251.5172
Fax: 301.251.5321

News Articles [52 Associated News Articles listed on BioPortfolio]

Incyte, MacroGenics sign licensing agreement for anti-PD-1 monoclonal antibody MGA012

Incyte and MacroGenics have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an investigational monoclonal antibody that inhibits programmed cell death p...

MacroGenics in deal to develop a novel bispecific molecule

US biotech firm MacroGenics has entered into a research collaboration and license agreement with Swiss…

MacroGenics finds new pharma partner in Roche

After being stung by J&J's recent decision to drop a clinical candidate, Macrogenics has lined up another early-stage collaboration deal. 

Roche partners with MacroGenics on bispecifics R&D

Roche Holding and MacroGenics agreed to work together to discover and develop bispecific molecules for undisclosed targets an -More- 

Incyte and MacroGenics Collaborate for Anti-PD-1 Monoclonal Antibody MGA012

WILMINGTON, Del. & ROCKVILLE, Md.–(BUSINESS WIRE)–Incyte Corporation (NASDAQ:INCY) and MacroGenics, Inc. (NASDAQ:MGNX) announced today that the companies have entered into an exclusive...

Roche schliesst Forschungspartnerschaft mit US-Unternehmen MacroGenics

Rockville (awp) - Der Basler Pharmakonzern Roche hat mit dem US-Biopharmaunternehmen MacroGenics eine Forschungszusammenarbeit zur Entwicklung eines neuartigen bispezifischen Moleküls zur Behandlun.....

Incyte to Develop MacroGenics' Cancer Immunotherapy MGA012 in Up-to-$900M+ Collab

Incyte will partner with MacroGenics to develop its Phase I cancer immunotherapy candidate MGA012, a monoclonal antibody designed to inhibit programmed cell death protein 1 (PD-1), through a collabora...

Incyte, MacroGenics partner on cancer immunotherapy study

Incyte will develop MacroGenics' early-stage cancer immunotherapy drug candidate MGA012 in a deal that could generate more th -More- 

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

MacroGenics Inc.

MacroGenics, Inc. is developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infec...

MacroGenics, Inc.

MacroGenics is a private, venture-backed biotechnology company that focuses on the discovery, development and delivery to patients of novel biologics for autoimmune disorders, cancer and infectious di...

Incyte Corporation and MacroGenics, Inc.

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additiona...

More Information about "MacroGenics Inc." on BioPortfolio

We have published hundreds of MacroGenics Inc. news stories on BioPortfolio along with dozens of MacroGenics Inc. Clinical Trials and PubMed Articles about MacroGenics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MacroGenics Inc. Companies in our database. You can also find out about relevant MacroGenics Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Corporate Database Quicklinks

Searches Linking to this Company Record